Reuters logo
9 个月内
BRIEF-CHMP recommends EU approval of Venclyxto in hard-to-treat CLL-Roche
2016年10月14日 / 上午11点18分 / 9 个月内

BRIEF-CHMP recommends EU approval of Venclyxto in hard-to-treat CLL-Roche

1 分钟阅读

Oct 14 (Reuters) - Roche Holding AG

* Says : roche announces CHMP recommendation for eu approval of venclyxto for people with hard-to-treat chronic lymphocytic leukaemia Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below